HemaSphere (Jun 2022)

P1240: ANTI-PD-1-ANTIBODY (TISLELIZUMAB) COMBINED WITH DEACETYLASE INHIBITOR (CHIDAMIDE), LENALIDOMIDE AND ETOPOSIDE FOR THE TREATMENT OF REFRACTORY/RELAPSED EXTRANODAL NATURAL KILLER/T CELL LYMPHOMA, NASAL

  • L. Zhang,
  • X. Liu,
  • X. Wang,
  • Y. Chang,
  • X. Fu,
  • X. Li,
  • L. Li,
  • X. Zhang,
  • J. Yan,
  • F. Nan,
  • L. Zhu,
  • Z. Sun,
  • H. Yu,
  • S. Guo,
  • W. Sang,
  • L. Wang,
  • M. Zhang

DOI
https://doi.org/10.1097/01.HS9.0000847824.69595.f0
Journal volume & issue
Vol. 6
pp. 1125 – 1126

Abstract

Read online

No abstracts available.